
Monte Rosa Therapeutics, an industry leader in targeted protein degradation (TPD), is seeking a passionate intern in Cell Biology to help us eliminate disease-causing proteins that were previously considered undruggable through our novel and exciting TPD platform. You will work closely with experienced scientists who will direct and mentor you on your project, while also exposing you to other drug discovery projects and involving you in solving complex biological questions. You will be joining a diverse, thoughtful, fun and collaborative environment that emphasizes teamwork and putting people first! This role is slated for a September 2026 or sonner start.

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.